| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.0B | $2.0B | $2.3B | $2.3B | $1.6B | $0.9B | $0.2B | $0.2B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $-0.1B | $-3.7B | $-2.0B | $-0.7B | $-0.7B | $-0.5B | $-0.2B | $-0.1B |
| Net Income | $0.4B | $-2.8B | $-1.6B | $0.2B | $-0.1B | $-0.2B | $0.0B | $-0.0B |
| EPS (Basic) | $1.96 | $-12.81 | $-7.41 | $0.82 | $-0.39 | $-1.24 | $0.11 | $-0.05 |
| EPS (Diluted) | $1.71 | $-12.81 | $-7.41 | $0.80 | $-0.39 | $-1.24 | $0.10 | $-0.05 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $22.6B | $19.9B | $20.5B | $19.3B | $16.5B | $14.4B | $5.8B | $4.7B |
| Current Assets | $2.2B | $1.7B | $1.9B | $2.1B | $1.5B | $1.1B | $0.7B | $0.5B |
| Cash & Equivalents | $0.8B | $0.6B | $0.7B | $0.7B | $0.6B | $0.5B | $0.3B | $0.2B |
| Total Liabilities | $17.6B | $15.7B | $13.5B | $11.1B | $8.9B | $7.1B | $4.2B | $3.3B |
| Current Liabilities | $1.3B | $1.3B | $1.5B | $1.2B | $1.0B | $0.9B | $0.5B | $0.4B |
| Stockholders' Equity | $3.1B | $2.6B | $5.2B | $6.7B | $6.3B | $6.1B | $1.0B | $0.9B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $-0.4B | $-0.8B | $-0.8B | $-0.8B | $-0.8B | $-0.3B | $-0.2B | $-0.1B |
| Investing Cash Flow | $-2.5B | $-2.7B | $-2.6B | $-2.1B | $-1.7B | $-0.5B | $-0.8B | $-0.8B |
| Capital Expenditures | — | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $3.2B | $3.4B | $3.5B | $3.0B | $2.6B | $1.2B | $1.1B | $0.9B |